Biodesix Historical Balance Sheet

BDSX Stock

USD 0.85 0.03 3.66%

Trend analysis of Biodesix balance sheet accounts such as Short Long Term Debt Total of 39.5 M, Other Current Liabilities of 15.9 M or Total Current Liabilities of 24.9 M provides information on Biodesix's total assets, liabilities, and equity, which is the actual value of Biodesix to its prevalent stockholders. By breaking down trends over time using Biodesix balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Biodesix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biodesix is a good buy for the upcoming year.

Biodesix Inventory

1.91 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

About Biodesix Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biodesix at a specified time, usually calculated after every quarter, six months, or one year. Biodesix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biodesix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biodesix currently owns. An asset can also be divided into two categories, current and non-current.

Biodesix Balance Sheet Chart

At this time, Biodesix's Cash And Short Term Investments are fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 136.2 M in 2025, whereas Total Assets are likely to drop slightly above 89.1 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Biodesix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biodesix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biodesix balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biodesix are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Biodesix's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biodesix current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.At this time, Biodesix's Cash And Short Term Investments are fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 136.2 M in 2025, whereas Total Assets are likely to drop slightly above 89.1 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	31.9M	60.7M	62.0M	39.5M
Total Assets	92.9M	99.1M	97.2M	89.1M

Short Long Term Debt Total Total Assets

Biodesix balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.56	0.69	0.85	0.96	-0.4	0.96	0.67	0.62	-0.33	-0.79	0.76	0.94	0.75	0.88	0.87	0.17	0.94	0.9	0.93	0.95	0.59	-0.94	0.83	0.98	0.97
Short Long Term Debt Total	0.56		0.44	0.42	0.47	-0.4	0.49	0.86	-0.12	0.53	-0.76	0.23	0.27	0.91	0.8	0.75	0.88	0.27	0.53	0.62	0.54	0.74	-0.43	0.1	0.48	0.61
Other Current Liab	0.69	0.44		0.84	0.78	-0.7	0.8	0.65	0.21	-0.12	-0.74	0.25	0.58	0.69	0.72	0.69	0.14	0.58	0.42	0.75	0.79	0.46	-0.82	0.6	0.7	0.77
Total Current Liabilities	0.85	0.42	0.84		0.83	-0.3	0.83	0.54	0.64	-0.32	-0.67	0.66	0.82	0.58	0.68	0.69	-0.02	0.82	0.78	0.8	0.83	0.35	-0.84	0.81	0.85	0.81
Total Stockholder Equity	0.96	0.47	0.78	0.83		-0.59	1.0	0.69	0.54	-0.34	-0.84	0.6	0.91	0.74	0.87	0.89	0.1	0.91	0.76	0.96	0.99	0.64	-0.99	0.85	0.97	0.98
Other Liab	-0.4	-0.4	-0.7	-0.3	-0.59		-0.6	-0.68	0.28	-0.17	0.74	0.27	-0.24	-0.66	-0.64	-0.65	-0.36	-0.24	0.0	-0.63	-0.63	-0.68	0.61	-0.24	-0.42	-0.58
Net Tangible Assets	0.96	0.49	0.8	0.83	1.0	-0.6		0.7	0.52	-0.33	-0.84	0.6	0.9	0.75	0.88	0.89	0.13	0.9	0.76	0.96	0.99	0.65	-0.99	0.84	0.97	0.98
Property Plant And Equipment Net	0.67	0.86	0.65	0.54	0.69	-0.68	0.7		-0.06	0.44	-0.95	0.19	0.41	0.94	0.84	0.9	0.69	0.41	0.51	0.78	0.77	0.95	-0.64	0.33	0.64	0.74
Current Deferred Revenue	0.62	-0.12	0.21	0.64	0.54	0.28	0.52	-0.06		-0.74	-0.12	0.87	0.78	-0.01	0.19	0.22	-0.54	0.78	0.76	0.46	0.48	-0.09	-0.54	0.85	0.66	0.48
Net Debt	-0.33	0.53	-0.12	-0.32	-0.34	-0.17	-0.33	0.44	-0.74		-0.21	-0.53	-0.6	0.3	0.02	0.07	0.76	-0.6	-0.3	-0.17	-0.23	0.43	0.39	-0.63	-0.38	-0.25
Retained Earnings	-0.79	-0.76	-0.74	-0.67	-0.84	0.74	-0.84	-0.95	-0.12	-0.21		-0.27	-0.6	-0.9	-0.9	-0.97	-0.52	-0.6	-0.58	-0.9	-0.9	-0.9	0.8	-0.5	-0.76	-0.86
Accounts Payable	0.76	0.23	0.25	0.66	0.6	0.27	0.6	0.19	0.87	-0.53	-0.27		0.82	0.29	0.42	0.41	-0.16	0.82	0.93	0.53	0.55	0.13	-0.58	0.77	0.75	0.61
Cash	0.94	0.27	0.58	0.82	0.91	-0.24	0.9	0.41	0.78	-0.6	-0.6	0.82		0.49	0.71	0.72	-0.13	1.0	0.86	0.82	0.87	0.36	-0.9	0.9	0.93	0.88
Non Current Assets Total	0.75	0.91	0.69	0.58	0.74	-0.66	0.75	0.94	-0.01	0.3	-0.9	0.29	0.49		0.94	0.89	0.72	0.49	0.58	0.82	0.78	0.84	-0.71	0.37	0.71	0.83
Non Currrent Assets Other	0.88	0.8	0.72	0.68	0.87	-0.64	0.88	0.84	0.19	0.02	-0.9	0.42	0.71	0.94		0.95	0.56	0.71	0.68	0.91	0.89	0.75	-0.85	0.51	0.82	0.93
Other Assets	0.87	0.75	0.69	0.69	0.89	-0.65	0.89	0.9	0.22	0.07	-0.97	0.41	0.72	0.89	0.95		0.51	0.72	0.68	0.92	0.92	0.85	-0.84	0.55	0.82	0.91
Long Term Debt	0.17	0.88	0.14	-0.02	0.1	-0.36	0.13	0.69	-0.54	0.76	-0.52	-0.16	-0.13	0.72	0.56	0.51		-0.13	0.12	0.26	0.18	0.64	-0.06	-0.35	0.07	0.25
Cash And Short Term Investments	0.94	0.27	0.58	0.82	0.91	-0.24	0.9	0.41	0.78	-0.6	-0.6	0.82	1.0	0.49	0.71	0.72	-0.13		0.86	0.82	0.87	0.36	-0.9	0.9	0.93	0.88
Net Receivables	0.9	0.53	0.42	0.78	0.76	0.0	0.76	0.51	0.76	-0.3	-0.58	0.93	0.86	0.58	0.68	0.68	0.12	0.86		0.76	0.75	0.43	-0.73	0.78	0.88	0.8
Good Will	0.93	0.62	0.75	0.8	0.96	-0.63	0.96	0.78	0.46	-0.17	-0.9	0.53	0.82	0.82	0.91	0.92	0.26	0.82	0.76		0.98	0.72	-0.95	0.77	0.94	0.98
Common Stock Total Equity	0.95	0.54	0.79	0.83	0.99	-0.63	0.99	0.77	0.48	-0.23	-0.9	0.55	0.87	0.78	0.89	0.92	0.18	0.87	0.75	0.98		0.72	-0.98	0.81	0.95	0.98
Common Stock Shares Outstanding	0.59	0.74	0.46	0.35	0.64	-0.68	0.65	0.95	-0.09	0.43	-0.9	0.13	0.36	0.84	0.75	0.85	0.64	0.36	0.43	0.72	0.72		-0.57	0.3	0.58	0.67
Non Current Liabilities Total	-0.94	-0.43	-0.82	-0.84	-0.99	0.61	-0.99	-0.64	-0.54	0.39	0.8	-0.58	-0.9	-0.71	-0.85	-0.84	-0.06	-0.9	-0.73	-0.95	-0.98	-0.57		-0.86	-0.96	-0.97
Inventory	0.83	0.1	0.6	0.81	0.85	-0.24	0.84	0.33	0.85	-0.63	-0.5	0.77	0.9	0.37	0.51	0.55	-0.35	0.9	0.78	0.77	0.81	0.3	-0.86		0.91	0.79
Other Current Assets	0.98	0.48	0.7	0.85	0.97	-0.42	0.97	0.64	0.66	-0.38	-0.76	0.75	0.93	0.71	0.82	0.82	0.07	0.93	0.88	0.94	0.95	0.58	-0.96	0.91		0.96
Other Stockholder Equity	0.97	0.61	0.77	0.81	0.98	-0.58	0.98	0.74	0.48	-0.25	-0.86	0.61	0.88	0.83	0.93	0.91	0.25	0.88	0.8	0.98	0.98	0.67	-0.97	0.79	0.96

Click cells to compare fundamentals

Biodesix Account Relationship Matchups

Biodesix balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	121.1M	76.1M	92.9M	99.1M	97.2M	89.1M
Short Long Term Debt Total	27.8M	10.0M	31.9M	60.7M	62.0M	39.5M
Other Current Liab	7.8M	25.4M	17.1M	29.9M	10.7M	15.9M
Total Current Liabilities	32.1M	29.0M	22.8M	33.4M	14.3M	24.9M
Total Stockholder Equity	41.2M	19.7M	20.6M	4.6M	20.9M	21.9M
Other Liab	29.8M	31.9M	17.4M	19.2M	17.3M	19.8M
Net Tangible Assets	(255.3M)	12.9M	(6.9M)	(4.2M)	(4.9M)	(5.1M)
Property Plant And Equipment Net	3.2M	4.2M	8.8M	29.6M	29.6M	31.1M
Current Deferred Revenue	3.5M	1.9M	962K	324K	678K	1.0M
Net Debt	(34.4M)	(22.7M)	(11.2M)	34.4M	35.7M	37.5M
Retained Earnings	(258.8M)	(302.0M)	(367.4M)	(419.6M)	(462.5M)	(485.6M)
Accounts Payable	9.0M	1.7M	1.7M	2.9M	2.2M	2.3M
Cash	62.1M	32.7M	43.1M	26.3M	26.2M	31.7M
Non Current Assets Total	34.9M	32.5M	39.6M	59.4M	57.8M	44.4M
Non Currrent Assets Other	3.5M	1.7M	5.9M	6.9M	7.3M	4.0M
Other Assets	90K	3.5M	1.7M	5.9M	6.8M	7.2M
Long Term Debt	15.9M	10.0M	25.0M	35.2M	36.4M	26.6M
Cash And Short Term Investments	62.1M	32.7M	43.1M	26.3M	26.2M	31.7M
Net Receivables	15.3M	3.7M	5.1M	7.7M	8.6M	7.5M
Common Stock Shares Outstanding	26.6M	27.4M	42.1M	82.1M	129.7M	136.2M
Liabilities And Stockholders Equity	121.1M	76.1M	92.9M	99.1M	97.2M	89.1M
Non Current Liabilities Total	47.8M	27.4M	49.5M	61.1M	62.1M	83.2M
Inventory	800K	3.2M	2.9M	1.4M	1.6M	1.9M
Other Current Assets	5.5M	4.3M	3.8M	4.3M	4.6M	4.2M
Other Stockholder Equity	421.0M	321.7M	387.9M	424.1M	483.2M	321.8M
Total Liab	79.9M	56.4M	72.3M	94.5M	76.4M	101.3M
Net Invested Capital	68.9M	29.7M	45.7M	39.9M	57.3M	60.2M
Property Plant And Equipment Gross	3.2M	4.2M	8.8M	35.2M	38.7M	40.7M
Total Current Assets	86.1M	43.6M	53.3M	39.7M	39.5M	44.8M
Capital Stock	27K	31K	78K	96K	145K	152.3K
Non Current Liabilities Other	31.9M	17.4M	19.2M	712K	815K	774.3K
Net Working Capital	54.0M	14.7M	30.5M	6.3M	25.2M	19.8M
Intangible Assets	13.3M	11.6M	9.8M	7.9M	5.9M	9.2M
Common Stock	27K	31K	78K	96K	145K	152.3K
Property Plant Equipment	2.1M	3.2M	4.2M	8.8M	10.1M	10.7M
Short Long Term Debt	11.8M	19K	49K	51K	21K	20.0K
Short Term Debt	11.8M	19K	3.1M	303K	740K	703K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biodesix Historical Balance Sheet

Biodesix Inventory

1.91 Million

About Biodesix Balance Sheet Analysis

Biodesix Balance Sheet Chart

Total Assets

Total Current Liabilities

Biodesix balance sheet Correlations

Biodesix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biodesix balance sheet Accounts

Also Currently Popular

Additional Tools for Biodesix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Common Stock Total Equity	+ 0.99	Total Stockholder Equity
Common Stock Total Equity	+ 0.99	Net Tangible Assets
Other Current Assets	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.98	Total Stockholder Equity

Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Non Current Liabilities Total	- 0.98	Common Stock Total Equity
Other Stockholder Equity	- 0.97	Non Current Liabilities Total
Other Assets	- 0.97	Retained Earnings
Other Current Assets	- 0.96	Non Current Liabilities Total